In vitro assessment of the potential for dolutegravir to affect hepatic clearance of levonorgestrel-Reference-Cited by-同舟云学术

In vitro assessment of the potential for dolutegravir to affect hepatic clearance of levonorgestrel

Published:2021-07-30 Issue:10 Volume:22 Page:898-906
ISSN:1464-2662
Container-title:HIV Medicine
language:en
Short-container-title:HIV Med

Author:

Roberts Owain¹,Kinvig Hannah¹,Owen Andrew²,Lamorde Mohammed³,Siccardi Marco¹^ORCID,Scarsi Kimberly K.⁴

Affiliation:

1. Department of Pharmacology and Therapeutics Institute of Systems, Molecular and Integrative Biology University of Liverpool Liverpool UK

2. Department of Pharmacology and Therapeutics Institute of Systems, Molecular and Integrative Biology Materials Innovation Factory University of Liverpool Liverpool UK

3. Infectious Diseases Institute College of Health Sciences Makerere University Kampala Uganda

4. College of Pharmacy University of Nebraska Medical Center Omaha NE USA

Funder

National Institutes of Health

Publisher

Wiley

Subject

Pharmacology (medical),Infectious Diseases,Health Policy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/hiv.13136

Reference56 articles.

1. Clinical Pharmacokinetic, Pharmacodynamic and Drug-Interaction Profile of the Integrase Inhibitor Dolutegravir

2. Neural-Tube Defects with Dolutegravir Treatment from the Time of Conception

3. Contraception for the HIV-Positive Woman: A Review of Interactions between Hormonal Contraception and Antiretroviral Therapy

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combined Oral Contraceptives As Victims of Drug Interactions;Drug Metabolism and Disposition;2023-03-24